Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RaScaL: Ranibizumab and Peripheral Laser for Diabetic Macular Edema
NCT00815360Phase 2Completed
- Sponsor
- Retina Associates of Florida
- Start
- Feb 2008
- Primary completion
- Jul 2011
- Modality
- Antibody Fragments, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of ranibizumab in diabetic macular edema (DME), sponsored by Retina Associates of Florida. Started Feb 2008; status: completed.
02
Drugs
ranibizumab
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT00815360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00815360.